Your browser doesn't support javascript.
loading
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial.
Janning, Melanie; Müller, Volkmar; Vettorazzi, Eik; Cubas-Cordova, Miguel; Gensch, Victoria; Ben-Batalla, Isabel; Zu Eulenburg, Christine; Schem, Christian; Fasching, Peter A; Schnappauf, Benjamin; Karn, Thomas; Fehm, Tanja; Just, Marianne; Kühn, Thorsten; Holms, Frank; Overkamp, Friedrich; Krabisch, Petra; Rack, Brigitte; Denkert, Carsten; Untch, Michael; Tesch, Hans; Rezai, Mahdi; Kittel, Kornelia; Pantel, Klaus; Bokemeyer, Carsten; Loibl, Sibylle; von Minckwitz, Gunter; Loges, Sonja.
Affiliation
  • Janning M; Department of Oncology, Hematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Müller V; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Vettorazzi E; Clinic and Policlinic for Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Cubas-Cordova M; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Gensch V; Department of Oncology, Hematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ben-Batalla I; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Zu Eulenburg C; Department of Oncology, Hematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schem C; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fasching PA; Department of Oncology, Hematology and Bone Marrow Transplantation with section Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schnappauf B; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Karn T; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fehm T; Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Just M; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
  • Kühn T; Department of Obstetrics and Gynecology, School of Medicine, Johann Wolfgang Goethe-University, Frankfurt, Germany.
  • Holms F; Department of Obstetrics and Gynecology, School of Medicine, Johann Wolfgang Goethe-University, Frankfurt, Germany.
  • Overkamp F; Department of Gynecology and Obstetrics, University Düsseldorf, Germany.
  • Krabisch P; Onkologische Schwerpunktpraxis Bielefeld, Bielefeld, Germany.
  • Rack B; Department of Gynecology and Obstetrics, Klinikum Esslingen, Esslingen, Germany.
  • Denkert C; Department of Gynecology and Obstetrics, St. Barbara Kliniken Heessen, Hamm, Germany.
  • Untch M; OncoConsult Hamburg GmbH, Hamburg, Germany.
  • Tesch H; Department of Gynecology and Obstetrics, Klinikum Chemnitz, Germany.
  • Rezai M; Department of Obstetrics and Gynecology, Campus Innenstadt, University Hospital Munich, Germany.
  • Kittel K; Department of Pathology, Charité Berlin Campus Mitte and German Cancer Consortium (DKTK), Berlin, Germany.
  • Pantel K; Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany.
  • Bokemeyer C; Centre for Hematology and Oncology, Frankfurt, Germany.
  • Loibl S; Centre for Breast Cancer, Luisenkrankenhaus Düsseldorf, Germany.
  • von Minckwitz G; Breast Cancer Day Clinic, Berlin, Germany.
  • Loges S; Department of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Int J Cancer ; 145(3): 857-868, 2019 08 01.
Article in En | MEDLINE | ID: mdl-30694523
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carbonic Anhydrase IX / Antigens, Neoplasm Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Int J Cancer Year: 2019 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carbonic Anhydrase IX / Antigens, Neoplasm Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Int J Cancer Year: 2019 Type: Article Affiliation country: Germany